Decibel Therapeutics Inc.

NASDAQ: DBTX · Real-Time Price · USD
4.91
-0.04 (-0.81%)
At close: Sep 22, 2023, 10:00 PM

Decibel Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2022 FY 2021
Period Ending Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a
Cost of Revenue
n/a n/a
Gross Profit
n/a n/a
Operating Income
-63.96M -50.23M
Interest Income
1.19M 193K
Pretax Income
-62.77M -50.03M
Net Income
-63.01M -51.82M
Selling & General & Admin
23.63M 20.38M
Research & Development
40.33M 29.85M
Other Expenses
n/a 12K
Operating Expenses
63.96M 50.23M
Interest Expense
1.19M n/a
Selling & Marketing Expenses
n/a n/a
Cost & Expenses
63.96M 50.23M
Income Tax Expense
240K 1.8M
Shares Outstanding (Basic)
24.96M 21.73M
Shares Outstanding (Diluted)
24.96M 21.73M
EPS (Basic)
-2.52 -2.38
EPS (Diluted)
-2.52 -2.38
EBITDA
-62.49M -48.82M
EBIT
-61.57M -50.23M
Depreciation & Amortization
1.46M 1.41M